Drug Side Effects
Search
INJECTION SITE VASCULITIS
INJECTION SITE VASCULITIS
was reported 57 times
INJECTION SITE VASCULITIS is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Anti-coagulant [EPC]
1
0.0003
1
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
2
0.0001
2
Antimycobacterial [EPC]
2
0.0001
3
Oxazolidinone Antibacterial [EPC]
2
0.0001
4
Interleukin-1 Receptor Antagonist [EPC]
1
0.0001
5
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
2
0.0000
6
PCSK9 Inhibitor [EPC]
1
0.0000
7
Proteasome Inhibitor [EPC]
4
0.0000
8
Penem Antibacterial [EPC]
1
0.0000
9
Nucleoside Metabolic Inhibitor [EPC]
8
0.0000
10
Interleukin-17A Antagonist [EPC]
1
0.0000
11
CTLA-4-directed Blocking Antibody [EPC]
1
0.0000
12
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
2
0.0000
13
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
2
0.0000
14
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
2
0.0000
15
Alkylating Drug [EPC]
3
0.0000
16
Anti-IgE [EPC]
1
0.0000
17
Interferon beta [EPC]
2
0.0000
18
P2Y12 Platelet Inhibitor [EPC]
1
0.0000
19
CD20-directed Cytolytic Antibody [EPC]
2
0.0000
20
Expectorant [EPC]
1
0.0000
21
GLP-1 Receptor Agonist [EPC]
2
0.0000
22
Osmotic Laxative [EPC]
1
0.0000
23
Corticosteroid [EPC]
4
0.0000
24
Tumor Necrosis Factor Blocker [EPC]
3
0.0000
25
Insulin Analog [EPC]
1
0.0000
26
Loop Diuretic [EPC]
1
0.0000
27
Interleukin-4 Receptor alpha Antagonist [EPC]
1
0.0000
28
Platelet Aggregation Inhibitor [EPC]
1
0.0000
29
Proton Pump Inhibitor [EPC]
1
0.0000
30
Nonsteroidal Anti-inflammatory Drug [EPC]
1
0.0000